ADIPOQ and obesity disorder: It has been demonstrated that a decreased adiponectin level caused by obesity-induced IR in the adipose tissue leads to decreased insulin sensitivity in the liver and skeletal muscle and, consequently, to IR-related metabolic phenotypes [19].